Document is current
Any future updates will be listed below
-
Authors
Lanitis, Evripidis
Irving, Melita https://orcid.org/0000-0002-6849-7194
Coukos, George https://orcid.org/0000-0001-8813-7367
- License Information
-
More Information
Article History
Accepted: 6 May 2025
First Online: 27 June 2025
Competing interests
: G.C. has received honoraria from Bristol-Myers Squibb. The CHUV has received honoraria for advisory services provided by G.C. to Iovance and EVIR. G.C. has also has received royalties from the University of Pennsylvania for CAR T cell therapy licensed to Novartis and Tmunity Therapeutics, and royalties from the Ludwig Institute for Cancer Research, UNIL and CHUV for NeoTIL intellectual property previously licensed to Tigen Pharma. G.C. is inventor in technologies related to T cell expansion and engineering for T cell therapy. The other authors declare no competing interests.
